Zogenix (ZGNX) Zohydro ER Fails to Win FDA Panel Backing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Oppenheimer Downgrades Zogenix, Inc. (ZGNX) to Perform
December 10, 2012 8:12 AM ESTOppenheimer downgraded Zogenix, Inc. (NASDAQ: ZGNX) from Outperform to Perform after the company fails to win FDA panel backing for Zohydro.
The firm comments, "On 12/7, ZGNX's Zohydro did not receive a positive recommendation from an FDA Advisory Committee, which cited safety concerns,... More
Zogenix's (ZGNX) Zohydro Unsafe to Treat Intended Patients, FDA Panel Says
December 7, 2012 3:29 PM ESTThe FDA panel now says that Zogenix's (NASDAQ: ZGNX) Zohydro is unsafe for intended patients. The panel voted 9 - 5 that the painkiller is unsafe.... More
FDA Panel Says Zogenix (ZGNX) Zohydro ER Effective to Treat Pain
December 7, 2012 2:54 PM ESTZogenix (NASDAQ: ZGNX) Zohydro ER effective to treat pain, FDA says. The vote was tight at 7 - 6.... More
Zogenix (ZGNX) Halted Ahead of FDA Committee Meeting for Zohydro ER NDA
December 7, 2012 7:02 AM ESTZogenix, Inc. (Nasdaq: ZGNX) announced that NASDAQ halted trading of the company's common stock on December 7, 2012. The U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is meeting today to review the Company's New Drug Application (NDA) for Zohydro ER (hydrocodone bitartrate extended-release capsules).... More
Zogenix (ZGNX) On Watch After FDA Briefing Docs Posted
December 5, 2012 8:06 AM ESTZogenix, Inc. (NASDAQ: ZGNX) is on watch as FDA briefing documents are posted.
Link... More
